Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HCCS | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | FKBP10 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | RARS | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | LCAT | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | S100A6 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | KIF1C | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | SLC12A4 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | S100A16 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | SPRYD7 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | TRIP10 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |